Festival of Genomics and Biodata, Boston (FOG Boston) 2024
)
Converging the genomics, other omics and biodata ecosystems under one roof, FOG Boston takes pharma/biotech, research and healthcare influencers on a journey towards the latest solutions that are transforming healthcare and medicine.
Oxford Nanopore are sponsoring, exhibiting and presenting at this event. Please stop by our booth #13 if you are attending.
Main Stage talk
Decoding the genetics of neurodegeneration with population-scale long-read sequencing
Date: Wednesday, June 12, 2024
Time: 4:50 PM to 5:20 PM ET
Location: Main Stage
This talk will focus on the CARD-long read initiative, whereby Dr. Billingsley and her team have developed scalable methods for population-scale Nanopore long read sequencing from human brain and blood samples. This framework has then been applied to generate whole-genome long-read data from hundreds of human samples. Using this they have characterized structural variation and began to assess the impact of these new variants on gene expression and methylation in the human brain.
Speakers
)
Heather Stark, Global Segment Marketing Manager, Oxford Nanopore TechnologiesAfter spending 15 years as a bench scientist for various organizations, Heather transitioned to the business world and now the Global Segment Manager for biopharma, working at Oxford Nanopore, a leading provider of third-generation DNA/RNA sequencing technologies.
)
Kimberley Billingsley, Postdoctoral Researcher, NIH Centre for Alzheimer's and Related DementiasKimberley Billingsley is leading the Long Read Sequencing Team at the Center for Alzheimer’s and Related Dementias at the NIH. Her work focuses on generating large-scale high value datasets to study the impact of structural variation in neurodegenerative diseases. Kimberley obtained her PhD from the University of Liverpool studying the role of Transposable Elements in Parkinson's Disease.
